Track 1: Cellular Immunology
| Main Symposium MS1.1 – T Cell Regulation Date&Time: TBA |
|||
| Chairs: Riitta LAHESMAA, Finland & Ann AGER, United Kingdom | |||
| Riitta LAHESMAA, Finland Molecular Mechanisms of Human T Cell Differentiation |
 |
 |
 |
| Shimon SAKAGUCHI, Japan Control of Immune Responses by Regulatory T Cells |
|||
| Dietmar ZEHN, Germany Origin, Effector Function, and Immunopathology Driving Potential of CD8 T Cells with or without an Exhausted Phenotype |
|||
| Main Symposium MS1.2 – Regulation of Adaptive Immune Responses Date&Time: TBA |
|||
| Chairs: Ahmet GUL,Turkey & Asimina FYLAKTOU, Greece | |||
| Claudia MAURI, United Kingdom Microbiota-Derived Metabolite in the Amelioration Arthritis: Novel Role of Serotonin Metabolites in B Cells Differentiation |
 |
 |
 |
| Jannie BORST, The Netherland Dendritic Cell Crosstalk in CD4 T Cell Help for the Cytotoxic T Cell Response |
|||
| Claudia KEMPER, USA A Novel and Human-Specific Role for the Complosome in the Regulation of Chromatin Landscapes |
|||
| Symposium S1.1 – Latest Insight on B Cell Effector Functions Date&Time: TBA |
|||
| Chairs: Marjolein van EGMOND, The Netherlands & Guher SARUHAN DIRESKENLI, Turkey | |||
| Marieke van HAM, The Netherland Dissecting Human in vitro Plasma Cell Differentiation Routes Using Single-Cell RNA Sequencing |
 |
 |
 |
| Simon FILLATREAU, France Regulatory Plasma Cells: Identification & Therapeutic Utilization |
|||
| Marion ESPELI, France Unravelling Novel Aspects of the Cell Biology of Plasma Cells |
|||
| Symposium S1.2 – Myeloid Cells Date&Time: TBA |
|||
| Chairs: Trevor OWENS, Denmark & Nada PEJNOVIC, Serbia | |||
| Massimo LOCATI, Italy Role of the Tetraspan MS4A4A Protein in Myeloid Cell Functions |
 |
 |
|
| Timo van den BERG, The Netherland The CD47-SIRP Alpha Myeloid Immune Checkpoint in Cancer |
|||
| Sarah WALMSLEY, United Kingdom Hypoxia Neutrophils and Inflammation |
|||
| Symposium S1.3 – NK Cell Biology from Basic Science to Clinical Therapy Date&Time: TBA |
|||
| Chairs: Eric VIVIER, France & Ofer MANDELBOIM, Israel | |||
| Carsten WATZL, Germany Inside the Mind of a Killer Novel Insights into the Cytotoxic Mechanisms of Natural Killer Cells |
 |
 |
 |
| Mira BARDA-SAAD, Israel Suppressing the Suppressors-Intracellular Inhibitory Checkpoint Pathways as Targets for Next-Generation NK-Cell Based Therapies |
|||
| Eric VIVIER, France Harnessing Innate Immunity for Patients: From Cancer to COVID-19 |
|||
| Symposium S1.4 – Regulatory T Cells in Health and Disease Date&Time: TBA |
|||
| Chairs: Jelena BEZBRADICA MIRKOVIC, United Kingdom & Markus FEUERER, Germany |
|||
| Markus FEUERER, Germany Regulatory T Cells in Nonlymphoid Tissues in Man and Mouse |
 |
 |
|
| Silvia PICONESE, Italy Metabolic Control of Treg Expansion in Cancer |
|||
| Olle KAMPE, Sweden Targets of the Immune System in the IPEX Syndrome |
|||
| Symposium S1.5 – EFIS-IL: B Cell Differentiation and Function in Health and Disease Date&Time: TBA |
|||
| Chairs: Jitka FUCIKOVA, Czech – Republic & Chrysoula NIKOLAOU, Greece |
|||
| Andrea CERUTTI, Spain New Insights into Mucosal Antibody Responses |
 |
 |
 |
| Lars NITSCHKE, Germany Siglecs: Inhibitors of B Cell Responses and Leukemia Progression |
|||
| Idit SHACHAR, Israel Molecular Mechanisms Regulating B Cell Survival in Health and Disease |
Track 2: Molecular Immunology
| MAIN SYMPOSIUM MS1.1 – Immunomodulation and Aging Date&Time: TBA |
|||
| Chairs: Megan MACLEOD, United Kingdom & TBA | |||
| Graham PAWELEC, Germany How can we predict vaccine responsiveness in older adults? |
 |
 |
 |
| Arne AKBAR, United Kingdom Altered Cellular Interaction Leading to Decreased Immunity During Ageing |
|||
| Anna Katharina SIMON, United Kingdom Role of Autophagy in Immune Aging |
|||
| MAIN SYMPOSIUM MS1.2 – Cell Death in Immunology Date&Time: TBA |
|||
| Chairs: TBA | |||
| Guido KROEMER, France Immunogenic Cell Death: Endogenous and Exogenous Adjuvant Signals |
 |
 |
|
| Mayda GURSEL, Turkey Elevated Type I IFN Levels Trigger NETosis in DNA Repair Deficiencies |
|||
| Arturo ZYCHLINSKY, Germany Extracellular Function in Immunity |
|||
| SYMPOSIUM S1.1 – Microbiota and the Immune System Date&Time: September 1, 2021 / 11:15 – 12:30 |
|||
| Chairs: Eva SVERREMARK-EKSTRÖM, Sweden & Ayca SAYI YAZGAN, Turkey | |||
| Eva SVERREMARK-EKSTROM, Sweden The Gut Environment as an Instructor for Immune Maturation and Function |
 |
 |
 |
| Emma SLACK, Switzerland Secretory Antibodies in the Intestinal Ecosystem |
|||
| Steffen JUNG, Israel Probing Tissue Macrophage Functions |
|||
| SYMPOSIUM S1.2 – Innate to Adaptive Date&Time: September 2, 2021 / 17:15 – 18:30 |
|||
| Chairs: Paloma Sanchez MATEOS, Spain & Winfried PICKL, Austria | |||
| Felix WENSVEEN, Croatia Why We Get Sick; Interactions Between the Immune and Endocrine Systems during Viral Infection |
 |
 |
 |
| Alexander SCHEFFOLD, Germany Antigen-Specificity in Human Immunopathologies |
|||
| Janneke SAMSOM, The Netherlands Loss of Innate and Adaptive Immune Regulation in Inflammatory Bowel Disease |
|||
| SYMPOSIUM S1.3 – Challenges in Vaccinology Date&Time: TBA |
|||
| Chairs: Africa González FERNANDEZ, Spain & Ursula WIEDERMANN, Austria | |||
| Rita CARSETTI, Italy Innate and Adaptive B Cell Memory: Pros and Cons of Specialization |
 |
 |
 |
| Ed LAVELLE, Ireland Novel Vaccine Adjuvant Strategies to Promote Cell Mediated Immunity |
|||
| Katrina POLLOCK, United Kingdom Self-Amplifying RNA Technology; Precision Vaccines for this Pandemic and the Next |
|||
| SYMPOSIUM S1.4 – COVID-19 Vaccine Development and Regulatory Issues: What We Have Learnt from the Pandemics? Date&Time: TBA |
|||
| Chairs: Stefan KAUFMANN, Germany & TBA | |||
| Peter HOTEZ, USA Vaccine Development and Fair Distribution Efforts during COVID-19 Pandemic |
 |
 |
 |
| Phil KRAUSE, USA Covid Vaccines & Regulatory Issues |
|||
| Grigor EFIMOV, Russia T Cell Responses of COVID-19 Patients |
|||
| SYMPOSIUM S1.5 – EFIS-IL: Non-Coding RNA and Epigenetic Regulation in Immune Cells Date&Time: TBA |
|||
| Chairs: Luljeta NEZIRI-AHMETAJ, Kosovo & Juergen WITMANN, Germany | |||
| Silvia MONTICELLI, Switzerland MicroRNA-Mediated Regulation of Primary Human T Lymphocytes |
 |
 |
|
| Gioacchina NATOLI, Italy The Macrophage Epigenome and the Control of Inflammatory Gene Expression |
|||
| Flavia BAZZONI, The Netherlands Regulation of Innate Immunity by Non-Coding RNAs |
|||
Track 3: Diseases and Immune Responses
| MAIN SYMPOSIUM MS1.1 – Mucosal Immune Response Date&Time: TBA |
|||
| Chairs: Kingston MILLS, Ireland & Constantin CAROLINA, Romania | |||
| Kingston MILLS, Ireland The Role of IL-17-Secreting Tissue-Resident Memory CD4 T Cells in Protection Against Bordetella Pertussisinfection of the Nasal Mucosae |
 |
 |
 |
| Bart LAMBRECHT, Belgium A crystal view on mucosal type 2 immunity in asthma |
|||
| Ludvig SOLLID, Norway Gut Immune Responses: What have We Learnt from Celiac Disease? |
|||
| MAIN SYMPOSIUM MS1.2 – Innate Immune Response Date&Time: September 2, 2021 / 11:30 – 13:00 |
|||
| Chairs: Mihai NETEA, The Netherlands & Sergei NEDOSPASOV,Germany | |||
| Shizuo AKIRA, Japan Regnase-1 as a Regulator of Metabolism and Immune Responses |
 |
 |
 |
| David SANCHO, Spain Connecting Myeloid Cell Metabolism and Function |
|||
| Mihai NETEA, The Netherlands Trained Immunity: A Memory for Innate Host Defense |
|||
| MAIN SYMPOSIUM MS1.3 – Autoimmune Diseases Date&Time: TBA |
|||
| Chairs: Renato MONTEIRO, France & Barbaros ORAL, Turkey | |||
| Romana HOEFTBERGER, Austria Neuropathology of Antibody-Associated Autoimmune Diseases of the Brain |
 |
 |
 |
| Burkhard BECHER, Switzerland T Cell-Phagocyte Crosstalk in Chronic Inflammation |
|||
| Marco PRINZ, Germany Myeloid Cell Diversity during Neuroinflammation |
|||
| SYMPOSIUM S1.1 – Immunometabolism Date&Time: TBA |
|||
| Chairs: Hannes STOCKINGER, Austria & Guadalupe SABIO, Spain | |||
| Marc VELDHOEN, Portugal Generating and Maintaining Tissue Resident T Cells |
 |
||
| Claudio MAURO, United Kingdom Metabolite-Mediated Regulation of Immune-Inflammation |
|||
| Guenter WEISS, Austria Regulatory Interaction Between Iron Homeostasis, Innate Immune Function and Infections |
|||
| SYMPOSIUM S1.2 – Aging of the Immune System Date&Time: TBA |
|||
| Chairs: Rene van LIER, The Netherlands & Delphine SAUCE, France | |||
| Delphine SAUCE, France Impact of Inflammatory Status on Resilience in the Elderly |
 |
 |
|
| Jacek M. WITKOWSKI, Poland Role of Modified Proteodynamics in Aging of the Immune System and Its Consequences |
|||
| Maria MITTELBRUNN, Spain T Cells in Age-Related Disorders |
|||
| SYMPOSIUM S1.3 – Immunotherapy in Transplantation Date&Time: TBA |
|||
| Chairs: Marcos Lopez HOYOS, Spain & Chiara ROMAGNANI, Germany | |||
| Jordi OCHANDO, Spain Targeting Trained Immunity in Transplantation and Cancer |
 |
 |
 |
| Giovanna LOMBARDI, United Kingdom The Future of Treg Therapy: From Polyclonal to Genetically Modified Tregs |
|||
| Christine FALK, Germany Immunotherapy and Chimerism on Organ Transplantation |
|||
| SYMPOSIUM S1.4 – Cell Signaling Date&Time: TBA |
|||
| Chairs: Sandra BEER-HAMMER, Germany & Alexandra TSIROGIANNI, Greece |
|||
| Sandra BEER-HAMMER, Germany The Role of SLy Proteins in Immune Responses |
 |
 |
 |
| Kjetil TASKEN, Norway Immunoregulatory Signal Networks and Tumor Immune Evasion Mechanisms |
|||
| Michael RETH, Germany The Humoral Immune Response against SARS-CoV2 |
|||
| SYMPOSIUM S1.5 – COVID-19 Vaccine Development Date&Time: TBA |
|||
| Chairs: Adrian HAYDAY, United Kingdom & Mayda GURSEL, Turkey | |||
| Francesco ANNUNZIATO, Italy Cell-mediated and humoral adaptive immune responses to Sars-CoV-2 S protein in COVID-19 patients and vaccinated subjects |
 |
 |
 |
| Teresa LAMBE, United Kingdom Story of the Development of Oxford Adenovirus Vector Based Vaccine Against COVID-19 Pandemic |
|||
| Florian KRAMMER, USA Correlates of Antibody Mediated Protection of COVID-19 Vaccine Candidates in Mice and in Human |
|||
Track 4: Innovative Technologies & Immunotherapies
| MAIN SYMPOSIUM MS1.1 – Immunological Mechanisms in Allergic Diseases and Immunotherapy Date&Time: TBA |
|||
| Chairs: Erika JENSEN-JAROLIM, Austria & TBA | |||
| Mübeccel AKDIS, Switzerland Novel B Cell Subsets and their Role in Immune Regulation |
 |
 |
|
| Rudolf VALENTA, Austria Prophylactic Vaccination of Allergy |
|||
| Mohamed SHAMJI, United Kingdom TBA |
|||
| MAIN SYMPOSIUM MS1.2 – Dendritic Cells in Immune Response Date&Time: TBA |
|||
| Chairs: Francesca GRANUCCI, Italy & Andrey TCHORBANOV, Bulgaria | |||
| Francesca GRANUCCI, Italy Dendritic Cells in COVID-19 and other Inflammatory Conditions |
 |
 |
 |
| Yvette VAN KOOYK, The Netherlands DC Targeted Nanovaccines for the Induction of Immunity or Tolerance |
|||
| Silvia GREGORI, Italy IL-10-Related Regulatory Cell Biology and Applications to Control Unwanted Immune Responses |
|||
| MAIN SYMPOSIUM MS1.3 – New technologies in Immunology Research Date&Time: TBA |
|||
| Chairs: TBA & Christoph BOCK, Austria | |||
| Muzlifah HANIFFA, United Kingdom Decoding the Developing Human Immune System |
 |
 |
 |
| Sarah TEICHMANN, United Kingdom Cell Atlas Technologies to Decipher Immunity |
|||
| Christoph BOCK, Austria High-Throughput Analysis of Immune (De-)Regulation in Hematopoietic Cells and in the Non-Hematopoietic, Structural Cells of the Body |
|||
| SYMPOSIUM S1.1 – Visualizing Lymphocytes Signaling Date&Time: TBA |
|||
| Chairs: Balbino ALARCON, Spain & Loredana SAVEANU, France | |||
| Loredana SAVEANU, France Endosomal Signaling via ITAM Coupled Immune Receptors |
 |
 |
|
| Claire HIVROZ, France Intracellular Traffic of Signaling Proteins: How does it Affect T Cell Activation? |
|||
| Erdinç SEZGİN, Sweden Using Synthetic Biology to Understand Immune Signalling |
|||
| SYMPOSIUM S1.2 – Cancer Immunotherapy Date&Time: TBA |
|||
| Chairs: Suhendan EKMEKCIOGLU, USA & Tanja de GRUJIL, The Netherlands |
|||
| Tolga SUTLU, Turkey Antigen-Specific Retargeting of Natural Killer Cells for Cancer Immunotherapy |
 |
 |
 |
| Linde MEYAARD, The Netherlands Novel Immune Checkpoint Receptors in Cancer Therapy |
|||
| Tanja de GRUIJL, The Netherlands Local Interventions with Global Impact: Targeting Tumor-Draining Lymph Nodes |
|||
| SYMPOSIUM S1.3 – Emerging Tools in Immune Response Date&Time: TBA |
|||
| Chairs: Arzu L. ARAL, Turkey & Katerina TARASSI, Greece | |||
| Romain RONCAGALLI, France Integrated Approaches to Decipher the TCR Signaling Network |
 |
 |
|
| Wolfgang PARAK, Germany Quantitative Tools to Investigate the Interaction of Colloidal Nanoparticles with Biology |
|||
| Ioannis THEODOROU, France Analyzing the Antibody Response with Machine Learning Algorithms |
|||
| SYMPOSIUM S1.4 – Perspectives in Single Cell Analysis Date&Time: TBA |
|||
| Chairs: Luis GRACA, Portugal & Muzzlifah HANIFFA, United Kingdom | |||
| Peter BRODIN, Sweden Human Systems Immunology |
 |
 |
 |
| Bertram BENGSCH, Germany Deep Immune Profiling of Exhausted T Cells by Mass Cytometry: Implications for Personalized Immunotherapy |
|||
| Mir-Farzin MASHREGHI, Germany Deciphering the Transcriptional and Clonal Heterogeneity of Adaptive Immune Cells in Chronic Inflammation |
|||
| SYMPOSIUM S1.5 – EFIS – IL: TCC_EUROPE: T Cells in High Dimension – from Individuality to Population Dynamics Date&Time: TBA |
|||
| Chairs: Wilfried ELLMEIER, Austria & Lucy WALKER, United Kingdom | |||
| Yang LI, The Netherlands Big Data Approach for Individualised Infection Medicine: Translating Genetic Variation into Immune Functions |
 |
 |
 |
| Michelle LINTERMAN, United Kingdom How Ageing Impacts the Immune Response to Vaccination |
|||
| Tom TAGHON, Belgium Dissection of the Molecular Mechanisms Controlling Human T Cell Development |